Agilent Technologies, Inc. has entered a collaboration with Seoul National University for a new research center that will support the College of Pharmacy’s New Drug Development Center. The collaboration will conduct drug metabolism studies and research to evaluate and develop new compounds, as well as assess toxicity and pharmacokinetics, and conduct clinical tests for drugs.
 
Agilent will provide bioanalytical instruments and expertise for drug testing and multi-omic biological systems. The jointly established research center will also serve as Agilent’s reference site for drug development. This new multi-purpose research center will house facilities for analysis, efficacy testing, medicinal ingredient research, as well as a medicinal chemistry lab.
 
“One of the megatrends fueling life science research is the aging population,” said Agilent’s Rod Minett, general manager, Life Sciences, South Korea and South Asia-Pacific region. “Through continual research, trials and developments, we believe that newer, more effective drugs can be developed. As such, Agilent is pleased to support SNU College of Pharmacy’s drive to create better drugs for a safer and healthier population.”